RSI Biotherapeutics Reports Positive Results from Proof-of-Concept Trial for First Investigational Compound
Mon / Jul 11th
Data supports theory that RSBT-001 can positively impact damaging inflammation without eliminating beneficial immune response CUMBERLAND, Md. – July 11,… Read More